Top-News

Breaking News: InnoCan startet in eine neue Ära – FDA Zulassung!(Anzeige)

Handeln

Zelira Therapeutics News


0,41 €		+0,49%	+0,002 €

08:01:56 Uhr Frankfurt

aktualisieren | Orderbuch | Mehr Kurse »

WKN: A2AS5H

ISIN: AU000000ZLD1

US-Symbol: ZLDAF

Typ: Aktie

Zelira Therapeutics News

20.09.22 - PR Newswire

Zelira Therapeutics Launches ZYRAYDI™ B2B Technology to Create Pharma-grade Cannabis Capsules & Tablets for Global Markets

Zelira Therapeutics Launches ZYRAYDI™ B2B Technology to Create Pharma-grade Cannabis Capsules & Tablets for Global Markets PR Newswire

21.07.22 - PR Newswire

Zelira's Zenivol™, the World's First Clinically Validated Cannabinoid Medication for Insomnia, Achieves Regulatory Approval in Germany

Zelira's Zenivol™, the World's First Clinically Validated Cannabinoid Medication for Insomnia, Achieves Regulatory Approval in Germany PR Newswire

23.09.21 - PR Newswire

Zelira™ Launches RAF FIVE™ Acne Treatment Products Through Its Dermatology Focused Subsidiary

Zelira™ Launches RAF FIVE™ Acne Treatment Products Through Its Dermatology Focused Subsidiary PR Newswire

15.12.20 - PR Newswire

Zelira Therapeutics Expands HOPE™ Distribution in the US Through Licensing Agreement with Alternative Solutions in Washington DC

Zelira Therapeutics Expands HOPE™ Distribution in the US Through Licensing Agreement with Alternative Solutions in Washington DC Agreement Signifies HOPE's Largest ...

30.08.06 - Aktiencheck

Gleneagle Gold chancenreich - Der Aktionär

Newssuche

Videos

09:10 Uhr -2,20%

Technical Trading: S&P 500 Short Chance

S&P 500 Short Typ: Turbo Open End WKN: UH45D5 Hebel: 2,11 Laufzeit: OpenEnd Einstieg: Market ... Mehr »

Der KI-Boom ist vorbei!

Aber dieser heiße Sektor verspricht, weiter zu wachsen...
weiterlesen»

Anzeige